Pfizer is recalling about 4.2M units of Nurtec ODT prescription drugs due to failure to meet child resistant packaging requirement; risk of poisoning. This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, NDC number and expiration date. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B
- Seagen downgraded to Equal Weight from Overweight at Morgan Stanley
- Pfizer’s deal in EU for Covid-19 vaccine meets some resistence, FT says
- JPMorgan biotech/pharma analysts to hold analyst/industry conference call
- Seagen price target raised to $229 from $155 at RBC Capital